{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:31:24Z","timestamp":1791822684940,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.hoc.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T19:33:55Z","timestamp":1440531235000},"page":"927-941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Macrophage Activation Syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Angelo","family":"Ravelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Dav\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Minoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy Q.","family":"Cron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2015.06.010_bib1","series-title":"Pediatric rheumatology","first-page":"55","article-title":"Macrophage activation syndrome","author":"Ravelli","year":"2008"},{"key":"10.1016\/j.hoc.2015.06.010_bib2","series-title":"Textbook of pediatric rheumatology","first-page":"674","article-title":"Macrophage activation syndrome","author":"Grom","year":"2010"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib3","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1097\/MD.0000000000000451","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients","volume":"94","author":"Bae","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.hoc.2015.06.010_bib4","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.24883","article-title":"Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients","volume":"60","author":"Parodi","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.md.0000224708.62510.d1","article-title":"Characteristic and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome","volume":"85","author":"Lambotte","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/pbc.22630","article-title":"Macrophage activation syndrome\/hemophagocytic lymphohistiocytosis and Kawasaki disease","volume":"55","author":"Simonini","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2015.06.010_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00296-006-0280-7","article-title":"Large pericardial effusion requiring pericardiocentesis as cardinal sign of macrophage activation syndrome in systemic onset-juvenile idiopathic arthritis","volume":"27","author":"Rigante","year":"2007","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/acr.20418","article-title":"Macrophage activation syndrome revealing familial Mediterranean fever","volume":"63","author":"Rossi-Semerano","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.hoc.2015.06.010_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3476(85)80072-X","article-title":"Acute hemorrhagic, hepatic and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection","volume":"106","author":"Hadchouel","year":"1985","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib10","first-page":"451","article-title":"Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases","volume":"11","author":"Stephan","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.hoc.2015.06.010_bib11","first-page":"2513","article-title":"Macrophage activation syndrome\u2013what's in a name!","volume":"30","author":"Ramanan","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.hoc.2015.06.010_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"Filipovich","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C","article-title":"Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic\/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society","volume":"29","author":"Favara","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib14","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.hoc.2015.06.010_bib16","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.hoc.2015.06.010_bib17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3899\/jrheum.141261","article-title":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"42","author":"Minoia","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.hoc.2015.06.010_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/BOR.0000000000000093","article-title":"Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis","volume":"26","author":"Weaver","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1203\/00006450-199810000-00001","article-title":"Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives","volume":"44","author":"Sullivan","year":"1998","journal-title":"Pediatr Res"},{"issue":"5446","key":"10.1016\/j.hoc.2015.06.010_bib23","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"Zur","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.hoc.2015.06.010_bib26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"Zur","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2015.06.010_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/asheducation-2005.1.82","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","author":"Janka","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.20140964","article-title":"Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time","volume":"212","author":"Jenkins","year":"2015","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.bor.0000381996.69261.71","article-title":"Macrophage activation syndrome: advances towards understanding pathogenesis","volume":"22","author":"Grom","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/art.20198","article-title":"Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?","volume":"50","author":"Grom","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.hoc.2015.06.010_bib33","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.23199","article-title":"Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis","volume":"58","author":"Hazen","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.hoc.2015.06.010_bib35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","article-title":"Genetic defects in cytolysis in macrophage activation syndrome","volume":"16","author":"Zhang","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.hoc.2015.06.010_bib36","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2014-11-610816","article-title":"Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion","volume":"125","author":"Spessott","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2015.06.010_bib37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s10875-011-9583-x","article-title":"Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children","volume":"31","author":"Yanagimachi","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"issue":"12","key":"10.1016\/j.hoc.2015.06.010_bib38","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/art.38793","article-title":"Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis","volume":"66","author":"Kaufman","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.hoc.2015.06.010_bib39","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib41","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-a-producing macrophages","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2015.06.010_bib42","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/art.10389","article-title":"Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima, et\u00a0al","volume":"46","author":"Maeno","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.hoc.2015.06.010_bib43","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/acr.21889","article-title":"Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis","volume":"65","author":"Kimura","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib45","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00002281-200209000-00012","article-title":"Macrophage activation syndrome","volume":"14","author":"Ravelli","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.hoc.2015.06.010_bib46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3899\/jrheum.121131","article-title":"Follistatin-like protein 1 and the ferritin\/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"40","author":"Gorelik","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib47","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3899\/jrheum.100833","article-title":"Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset Still's disease: 3 cases","volume":"38","author":"Gorelik","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.hoc.2015.06.010_bib48","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jpeds.2012.11.081","article-title":"Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis","volume":"162","author":"Lehmberg","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/BOR.0b013e32825a6a79","article-title":"Recognition and management of macrophage activation syndrome in juvenile arthritis","volume":"19","author":"Kelly","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"25","key":"10.1016\/j.hoc.2015.06.010_bib50","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.hoc.2015.06.010_bib51","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hoc.2015.06.010_bib52","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.2003.017798","article-title":"Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity","volume":"63","author":"De Kleer","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hoc.2015.06.010_bib53","first-page":"70","article-title":"The paradox of macrophage activation syndrome triggered by biologic medications","volume":"3","author":"Buoncompagni","year":"2005","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib54","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib55","first-page":"197","article-title":"Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society","volume":"10","author":"Arico","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2015.06.010_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","article-title":"Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability","volume":"141","author":"Ho","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hoc.2015.06.010_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/apr.020620120233","article-title":"Toward the development of new diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"1","author":"Dav\u00ec","year":"2012","journal-title":"Ann Paediatr Rheumatol"},{"issue":"1","key":"10.1016\/j.hoc.2015.06.010_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1651-2227.1986.tb10158.x","article-title":"Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis","volume":"75","author":"Pelkonen","year":"1986","journal-title":"Acta Paediatr Scand"},{"issue":"10","key":"10.1016\/j.hoc.2015.06.010_bib59","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/art.38769","article-title":"Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"66","author":"Davi","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib60","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3899\/jrheum.100996","article-title":"An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"38","author":"Davi","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.hoc.2015.06.010_bib61","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","article-title":"Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases","volume":"129","author":"Mouy","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3476(96)70408-0","article-title":"Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine","volume":"128","author":"Ravelli","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.hoc.2015.06.010_bib63","first-page":"2120","article-title":"Etanercept in the treatment of macrophage activation syndrome","volume":"28","author":"Prahalad","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib64","first-page":"401","article-title":"Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis","volume":"30","author":"Ramanan","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.hoc.2015.06.010_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","article-title":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients","volume":"50","author":"Miettunen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.hoc.2015.06.010_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/RHU.0b013e318205092d","article-title":"Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids","volume":"17","author":"Bruck","year":"2011","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.hoc.2015.06.010_bib67","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/ncprheum0919","article-title":"A\u00a0case of macrophage activation syndrome successfully treated with anakinra","volume":"4","author":"Kelly","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.hoc.2015.06.010_bib68","first-page":"79","article-title":"Macrophage activation syndrome (MAS) during anti-IL1 therapy (anakinra) in a patient affected by systemic juvenile arthritis (soJIA): a report and review of the literature","volume":"3","author":"Lurati","year":"2005","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.hoc.2015.06.010_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/RHU.0b013e3181a4f459","article-title":"Anakinra for systemic juvenile arthritis: the Rocky Mountain experience","volume":"15","author":"Zeft","year":"2009","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"9617","key":"10.1016\/j.hoc.2015.06.010_bib70","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2015.06.010_bib71","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/s10165-010-0348-9","article-title":"Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome","volume":"21","author":"Kobayashi","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.hoc.2015.06.010_bib72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3899\/jrheum.100726","article-title":"Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series","volume":"38","author":"Record","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.hoc.2015.06.010_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2009.02.005","article-title":"Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin","volume":"132","author":"Coca","year":"2009","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.hoc.2015.06.010_bib74","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.hoc.2015.06.010_bib75","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10067-011-1720-7","article-title":"Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis","volume":"30","author":"Alexeeva","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.hoc.2015.06.010_bib76","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MPH.0b013e3180f61be3","article-title":"Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"29","author":"Balamuth","year":"2007","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2015.06.010_bib77","first-page":"364","article-title":"The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis","volume":"67","author":"Bosman","year":"2009","journal-title":"Neth J Med"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858815000878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858815000878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:02:33Z","timestamp":1760184153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858815000878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0889858815000878"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2015.06.010","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage Activation Syndrome","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}